| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/28/2004 | EP1440709A2 Combinations comprising cGMP PDE5 inhibitors. |
| 07/28/2004 | EP1440686A1 Aerosol compositions |
| 07/28/2004 | EP1440682A1 Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis |
| 07/28/2004 | EP1440619A1 Fat based food products comprising sterols |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440165A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/28/2004 | EP1440163A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 07/28/2004 | EP1440159A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/28/2004 | EP1440143A1 Device with recessed tracks for forming a cellular network |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440080A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
| 07/28/2004 | EP1439864A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/28/2004 | EP1439849A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 07/28/2004 | EP1439848A1 L-methionine as a stabilizer for nesp/epo in hsa-free formulations |
| 07/28/2004 | EP1439847A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
| 07/28/2004 | EP1439842A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1439840A1 Monobactam antibacterial compounds and methods of use thereof |
| 07/28/2004 | EP1439839A1 A combination comprising combretastatin and anticancer agents |
| 07/28/2004 | EP1439836A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
| 07/28/2004 | EP1439825A1 Methods of treatment using a gastric retained gabapentin dosage |
| 07/28/2004 | EP1311660A4 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 07/28/2004 | EP1284749B1 Use of hyaluronidase for preventing and treating cardio vascular diseases |
| 07/28/2004 | EP1267858B1 Diphenyl ketoaldehyde derivatives with anti-hiv activity |
| 07/28/2004 | EP1220667B1 Beta-agonists for treating endometriosis or infertility, or improving fertility |
| 07/28/2004 | EP1073430B1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
| 07/28/2004 | EP1061802B1 Topical carbamazepine formulations and methods of use |
| 07/28/2004 | EP1058546A4 Composition and method for treating macular disorders |
| 07/28/2004 | EP0957919A4 Analgesic composition for treatment of migraine headaches |
| 07/28/2004 | EP0831821B1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 07/28/2004 | EP0696201B1 Supplemented tissue sealants, methods of their production and use |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516693A Benzimidazoles that are useful in treating sexual dysfunction |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516601A Orally deliverable pharmaceutical composition comprising drug of low water solubility (cox-2 inhibitor), solvent, fatty acid and organic amine |
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516599A Method for joint treatment of chronic hepatitis C infection using ribavirin-polyvinyl glycol interferon alpha |
| 07/28/2004 | CN1516590A 4'-substituted nucleosides |
| 07/28/2004 | CN1516588A Combination of brimonidine and timolol for topical ophthalmic use |
| 07/28/2004 | CN1516582A 抗病毒化合物 Antiviral compounds |
| 07/28/2004 | CN1516581A Amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and removing free radical antioxidate and liquid |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515317A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515316A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515261A Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 07/28/2004 | CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor |
| 07/28/2004 | CN1515258A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515257A Paroxetine control-released composite |
| 07/28/2004 | CN1515254A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515253A New application of 1,3-propylene glycol derivative |
| 07/28/2004 | CN1515244A Protein-stable pharmacological active matter, its preparation and application method |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159333C Trichina antigen gene Ts 87 and use thereof |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/28/2004 | CN1159306C Substituted 8,8a-dihydro-3aH-indeno[1,2-D] thiazoles, a method for their production and their use as medicaments |
| 07/28/2004 | CN1159287C Anticonvulsant and sentral nervous system-active bis (fluorophenyl) alkylamides |
| 07/28/2004 | CN1159061C Treatment of infarcts through inhibition of NF-KAPPAB |
| 07/28/2004 | CN1159012C Pharmaceutical composition of combination of piperidinoalkanol-decongestant |
| 07/28/2004 | CN1158994C Topcial suspension formulations containing cirporfloxacin and dexa methasone |
| 07/27/2004 | US6767926 Pretreatment with alpha, beta-unsaturated aryl sulfone as cytoprotectant; side effect reduction during cancer treatment; mitotic phase cell cycle inhibitor or topoisomerase inhibitors |
| 07/27/2004 | US6767924 Method of using hydroxycarboxylic acids or related compounds for treating skin changes associated with intrinsic and extrinsic aging |
| 07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767705 Recombinant expression construct encoding a reporter gene operably linked to a promoter from a gene the expression of which is induced by a retinoid, wherein the promoter does not contain a retinoic acid response elements site |
| 07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
| 07/27/2004 | US6767554 Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments |
| 07/27/2004 | US6767544 Methods for treating cardiovascular diseases with botulinum toxin |
| 07/27/2004 | US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 07/27/2004 | US6767531 High dose radionuclide complexes for bone marrow suppression |
| 07/27/2004 | CA2251197C The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders |
| 07/27/2004 | CA2219911C Combinations for the treatment of parkinsonism containing selective nmda antagonists |
| 07/24/2004 | CA2428744A1 Inhibition of lysozyme in treating sepsis-induced myocardial dysfunction |
| 07/22/2004 | WO2004060920A1 Complexes of protein crystals and ionic polymers |
| 07/22/2004 | WO2004060911A2 Combination therapy with co-stimulatory factors |
| 07/22/2004 | WO2004060878A2 Inhibitors of phosphatases |
| 07/22/2004 | WO2004060487A2 Composition for the treatment of hiv or aids |
| 07/22/2004 | WO2004060402A1 Method and material for specific proliferation promotion of lymphocyte sub-populations by means of a combination of an immunomodulator with a non-water-soluble natural product and a carrier |
| 07/22/2004 | WO2004060379A2 Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications |
| 07/22/2004 | WO2004060374A1 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 07/22/2004 | WO2004060372A1 Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer |
| 07/22/2004 | WO2004060370A1 Treatment of hiv infection through combined administration of tipranavir and capravirine |
| 07/22/2004 | WO2004060369A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes |
| 07/22/2004 | WO2004060368A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 07/22/2004 | WO2004060366A1 A method for the treatment, prevention, or inhibition of a cns disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
| 07/22/2004 | WO2004060361A2 Combination of reboxetine and a cyclooxygenase-2 inhibitor |
| 07/22/2004 | WO2004060360A1 Use of active ingredients for the prophylaxis and/or therapy of viral diseases |
| 07/22/2004 | WO2004060355A1 Multilayer Dosage Forms Containing NSAIDs and Triptans |
| 07/22/2004 | WO2004060348A2 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 07/22/2004 | WO2004060345A2 Dispersible pharmaceutical compositions |
| 07/22/2004 | WO2004060321A2 Cardioprotective delta opioid receptor agonists and methods of using same |
| 07/22/2004 | WO2004060319A2 Immunostimulatory combinations |
| 07/22/2004 | WO2004060317A2 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
| 07/22/2004 | WO2004060304A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060303A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 07/22/2004 | WO2004060302A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | WO2004060291A2 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | WO2004060284A2 Method of using colloidal metal-protein composition for treatment of cancer |